Phase 0 lead-in trial of Pitavastatin in primary and recurrent Glioblastoma patients

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505743-38-00

Acronym

10227

Enrollment

Registered

2023-10-16

Start date

2024-01-18

Completion date

2024-07-19

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma Multiforme

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026